Saturday, December 3, 2022

F.D.A.’s Drug Industry Fees Fuel Concerns Over Influence

Trending News

The pharmaceutical industry finances about 75 percent of the agency’s drug division, through a controversial program that Congress must reauthorize by the end of this month.

Every five years, top officials of the Food and Drug Administration go behind closed doors to negotiate the terms of its core budget — about $3 billion this year.

But the F.D.A. is not at the table with members of Congress or with White House officials. Instead, it’s in dozens of meetings with representatives of the giant pharmaceutical companies whose products the agency regulates. The negotiations are a piece of the “user fee” program in which drug, device and biotech companies make payments to the agency partly to seek product approvals. The fees have soared since the program’s inception three decades ago and now make up nearly half of the F.D.A.’s budget and finance 6,500 jobs at the agency.

Read Full Coverage Here

Disclaimer: This story is generated from RSS Feed and has not been created or edited by Waba News. Publisher: The New York Times

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -
Latest News

Concerns over Cummins as Smith takes the reins

Cricket Australia explained captain was battling some sorenessCummins bowled 20.2 overs in West Indies first innings across days two...
- Advertisement -
- Advertisement -

More Stories Like This